Peanut allergy Clinical Trials

14 recruitingLast updated: June 18, 2026

There are 14 actively recruiting peanut allergy clinical trials across 9 countries. Studies span Phase 2, Phase 1, Not Applicable, Phase 3. Top locations include Boston, Massachusetts, United States, Chapel Hill, North Carolina, United States, Atlanta, Georgia, United States. Updated daily from ClinicalTrials.gov.


Peanut allergy Trials at a Glance

14 actively recruiting trials for peanut allergy are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Phase 2 with 7 trials, with the heaviest enrollment activity in Boston, Chapel Hill, and Atlanta. Lead sponsors running peanut allergy studies include Dr Tim Chataway, InnoUp Farma S.L., and DBV Technologies.

Browse peanut allergy trials by phase

Treatments under study

About Peanut allergy Clinical Trials

Looking for clinical trials for Peanut allergy? There are currently 21 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Peanut allergy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Peanut allergy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Phase 1

Safety of MOON101 for the Treatment of Peanut Allergy

Peanut allergy
Moonlight Therapeutics, Inc.40 enrolled5 locationsNCT07580898
Recruiting
Not Applicable

Investigating Modified Protocols of Oral Immunotherapy to Validate Efficacy and Safety

Egg allergyPeanut allergyMilk Allergy, Cow's
McGill University Health Centre/Research Institute of the McGill University Health Centre360 enrolled1 locationNCT06256146
Recruiting
Phase 1Phase 2

Study of ENP-501 in Peanut-Allergic and Non-Allergic Participants

Peanut allergy
N-Fold, LLC68 enrolled1 locationNCT07117669
Recruiting
Phase 2

Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis

Milk and/or Peanut Allergy
National Institute of Allergy and Infectious Diseases (NIAID)200 enrolled1 locationNCT03835767
Recruiting
Phase 1Phase 2

UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies

Peanut allergyPeanut-Induced Anaphylaxis
Ukko Inc40 enrolled5 locationsNCT07349212
Recruiting
Phase 3

Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)

AllergyPeanut allergy
DBV Technologies480 enrolled90 locationsNCT07003919
Recruiting
Phase 2

Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients

Food allergyPeanut allergyFood Allergy Peanut+3 more
Rima Rachid37 enrolled1 locationNCT05695261
Recruiting
Not Applicable

Using Commonly Available Food Products To Treat Food Allergy

Peanut allergyIgE-Mediated Cow Milk Allergy
University of Southampton216 enrolled5 locationsNCT05503446
Recruiting
Phase 1Phase 2

Oral Immunotherapy for Peanut Allergic Patients

Peanut allergy
InnoUp Farma S.L.50 enrolled2 locationsNCT04163562
Recruiting
Not Applicable

Immune-supportive Diet and Gut Permeability in Allergic Children

Nut AllergyPeanut allergy
Onze Lieve Vrouwe Gasthuis132 enrolled1 locationNCT05667610
Recruiting

Eating nuts while breastfeeding – the Nuts For Babies Study.

IgE-mediated cashew nut allergyIgE-mediated peanut allergy
The Kids Research Institute Australia4,412 enrolled1 locationACTRN12624000134527
Recruiting
Phase 1Phase 2

VE416 for Treatment of Food Allergy

Peanut allergy
Massachusetts General Hospital60 enrolled1 locationNCT03936998
Recruiting

SmartStartAllergy - a novel SMS and smartphone based application to monitor infants starting solid foods and support implementation of infant feeding guidelines

Peanut allergy
Michael O'Sullivan2,500 enrolled1 locationACTRN12620000025932
Recruiting
Phase 2

HYPES: Peanut allergy desensitisation using sequential hypoallergenic and roasted peanuts

Peanut allergy
Dr Tim Chataway75 enrolled1 locationACTRN12617000803392